Suppr超能文献

关于益生菌安全性的评论。

A commentary on the safety of probiotics.

机构信息

Department of Medicine, Alimentary Pharmabiotic Centre, University College Cork, National University of Ireland, Galway, Ireland.

出版信息

Gastroenterol Clin North Am. 2012 Dec;41(4):869-76. doi: 10.1016/j.gtc.2012.08.006.

Abstract

Probiotics have a long record of safety, which relates primarily to lactobacilli and bifidobacteria. Experience with other forms of probiotic is more limited. There is no such thing as zero risk, particularly in the context of certain forms of host susceptibility. There is poor public understanding of the concept of risk, in general, and risk/benefit analysis, in particular. Uncertainty persists regarding the potential for transfer of antibiotic resistance with probiotics, but the risk seems to be low with currently available probiotic products. As with other forms of therapeutics, the safety of probiotics should be considered on a strain-by-strain basis.

摘要

益生菌的安全性记录由来已久,这主要与乳杆菌属和双歧杆菌属有关。其他形式的益生菌的经验则更为有限。在某些宿主易感性的情况下,没有零风险这回事。一般来说,公众对风险概念和风险/收益分析的理解很差。关于益生菌可能具有抗生素耐药性转移的潜力仍然存在不确定性,但目前可用的益生菌产品的风险似乎很低。与其他形式的治疗方法一样,应该逐株考虑益生菌的安全性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验